Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-01-10

Clinical Trial Update: Selenium and Vitamin E in Preventing Cancer Progression and Recurrence in Patients With Early-Stage Bladder Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update investigating whether selenium and vitamin E can prevent progression and recurrence of early-stage bladder cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Selenium (selenium)
  • Vitamin E (tocopherol)

Snippet

Sponsor: University of Birmingham | Conditions: Bladder Cancer | Phase 3 | Status: UNKNOWN